In this episode, Dr. Edward Schaeffer, chair of urology at Feinberg School of Medicine, discusses precision medicine in prostate cancer with Dr. Aditya Bagrodia.

First, Dr. Schaeffer introduces the importance of using a defined screening strategy for prostate cancer that includes analyzing a patient’s genomic and germline risk. Then, he summarizes existing and new diagnostic tools for prostate cancer. Additionally, Dr. Schaeffer discusses genomic testing and PSMA testing and explains how he applies them to individual patient cases depending on their cancer stage and grade. Finally, the doctors highlight the ability of future tools, like PET PSMA scans, to advance precision medicine.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/3XO8iL

---

SHOW NOTES

00:00 - Introduction
10:32 - Precision Medicine and Prostate Cancer
16:17 - Screening and Diagnosis of Prostate Cancer
29:41 - Personalizing Surveillance and Disease Management
33:11 - The Role of Genomic Testing in Prostate Cancer
45:00 - The Use of PET PSMA Scans in Prostate Cancer Staging
48:08 - The Future of Precision Medicine in Prostate Cancer